[Form 4] Orchestra BioMed Holdings, Inc. Insider Trading Activity
Orchestra BioMed Holdings, Inc. (OBIO) reporting person Darren Sherman, identified as President and Chief Operating Officer, acquired 3,000 shares of the company's common stock on 08/25/2025 at a price of $2.62 per share. Following the transaction, Mr. Sherman directly beneficially owns 926,837 shares. The Form 4 was signed by an attorney-in-fact.
Orchestra BioMed Holdings, Inc. (OBIO), la persona che ha effettuato la segnalazione Darren Sherman, identificato come Presidente e Chief Operating Officer, ha acquistato 3.000 azioni del capitale sociale della societ脿 il 25/08/2025 al prezzo di $2,62 per azione. A seguito della transazione, il Sig. Sherman detiene direttamente e a titolo beneficiario 926.837 azioni. Il Modulo 4 猫 stato firmato da un procuratore.
Orchestra BioMed Holdings, Inc. (OBIO), la persona informante Darren Sherman, identificado como Presidente y Director de Operaciones, adquiri贸 3.000 acciones del capital social de la compa帽铆a el 25/08/2025 a un precio de $2,62 por acci贸n. Tras la operaci贸n, el Sr. Sherman posee directa y beneficiariamente 926.837 acciones. El Formulario 4 fue firmado por un apoderado.
Orchestra BioMed Holdings, Inc. (OBIO)鞚� 氤搓碃鞛� Darren Sherman鞚� 靷灔 瓴� 斓滉碃鞖挫榿毂呾瀯鞛�搿� 頇曥澑霅橂┌, 2025-08-25鞐� 須岇偓 氤错喌欤� 3,000欤�毳� 欤茧嫻 $2.62鞐� 旆摑頄堨姷雼堧嫟. 頃措嫻 瓯半灅 鞚错泟 Sherman 鞌姅 歆侅爲鞝侅溂搿� 順滍儩鞚� 氚涬姅 順曧儨搿� 926,837欤�毳� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. Form 4電� 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
Orchestra BioMed Holdings, Inc. (OBIO), la personne d茅clarante Darren Sherman, identifi茅 comme Pr茅sident et Chief Operating Officer, a acquis 3 000 actions de l'actionnariat de la soci茅t茅 le 25/08/2025 au prix de 2,62 $ par action. 脌 la suite de la transaction, M. Sherman poss猫de directement et 脿 titre b茅n茅ficiaire 926 837 actions. Le formulaire 4 a 茅t茅 sign茅 par un mandataire.
Orchestra BioMed Holdings, Inc. (OBIO), die meldende Person Darren Sherman, ausgewiesen als President und Chief Operating Officer, erwarb am 25.08.2025 3.000 Aktien des Stammkapitals des Unternehmens zu einem Preis von $2,62 je Aktie. Nach der Transaktion h盲lt Herr Sherman unmittelbar wirtschaftlich berechtigt 926.837 Aktien. Das Formular 4 wurde von einem Bevollm盲chtigten unterzeichnet.
- Insider acquisition disclosed: 3,000 shares purchased at $2.62 per share
- Clear role identified: Reporting person is President and Chief Operating Officer
- Post-transaction ownership disclosed: 926,837 shares beneficially owned (direct)
- None.
Insights
TL;DR: Insider purchase of 3,000 shares by the COO is a routine Form 4 disclosure with limited market impact.
The filing documents a small open-market acquisition by a senior executive: 3,000 shares at $2.62 each, raising direct beneficial ownership to 926,837 shares. This is a factual disclosure of insider activity without accompanying material corporate events, financial results, or changes to outstanding equity that would alter valuation materially.
TL;DR: Disclosure meets Section 16 reporting requirements; transaction appears properly documented and signed by an attorney-in-fact.
The Form 4 identifies the reporting person, role (President and COO), transaction details, and the post-transaction ownership amount. The signature block shows an attorney-in-fact executed the form. No amendments or additional governance actions are reported in this filing.
Orchestra BioMed Holdings, Inc. (OBIO), la persona che ha effettuato la segnalazione Darren Sherman, identificato come Presidente e Chief Operating Officer, ha acquistato 3.000 azioni del capitale sociale della societ脿 il 25/08/2025 al prezzo di $2,62 per azione. A seguito della transazione, il Sig. Sherman detiene direttamente e a titolo beneficiario 926.837 azioni. Il Modulo 4 猫 stato firmato da un procuratore.
Orchestra BioMed Holdings, Inc. (OBIO), la persona informante Darren Sherman, identificado como Presidente y Director de Operaciones, adquiri贸 3.000 acciones del capital social de la compa帽铆a el 25/08/2025 a un precio de $2,62 por acci贸n. Tras la operaci贸n, el Sr. Sherman posee directa y beneficiariamente 926.837 acciones. El Formulario 4 fue firmado por un apoderado.
Orchestra BioMed Holdings, Inc. (OBIO)鞚� 氤搓碃鞛� Darren Sherman鞚� 靷灔 瓴� 斓滉碃鞖挫榿毂呾瀯鞛�搿� 頇曥澑霅橂┌, 2025-08-25鞐� 須岇偓 氤错喌欤� 3,000欤�毳� 欤茧嫻 $2.62鞐� 旆摑頄堨姷雼堧嫟. 頃措嫻 瓯半灅 鞚错泟 Sherman 鞌姅 歆侅爲鞝侅溂搿� 順滍儩鞚� 氚涬姅 順曧儨搿� 926,837欤�毳� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. Form 4電� 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
Orchestra BioMed Holdings, Inc. (OBIO), la personne d茅clarante Darren Sherman, identifi茅 comme Pr茅sident et Chief Operating Officer, a acquis 3 000 actions de l'actionnariat de la soci茅t茅 le 25/08/2025 au prix de 2,62 $ par action. 脌 la suite de la transaction, M. Sherman poss猫de directement et 脿 titre b茅n茅ficiaire 926 837 actions. Le formulaire 4 a 茅t茅 sign茅 par un mandataire.
Orchestra BioMed Holdings, Inc. (OBIO), die meldende Person Darren Sherman, ausgewiesen als President und Chief Operating Officer, erwarb am 25.08.2025 3.000 Aktien des Stammkapitals des Unternehmens zu einem Preis von $2,62 je Aktie. Nach der Transaktion h盲lt Herr Sherman unmittelbar wirtschaftlich berechtigt 926.837 Aktien. Das Formular 4 wurde von einem Bevollm盲chtigten unterzeichnet.
FAQ
What transaction did Darren Sherman report on Form 4 for OBIO?
What is Darren Sherman鈥檚 role at Orchestra BioMed (OBIO)?
How many OBIO shares does Darren Sherman own after the reported transaction?
Was the Form 4 signed by the reporting person?
Does the Form 4 indicate an amendment or multiple filers?
